a biotechnology company, which engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology.
Industry Biotechnology
A.I.dvisor indicates that over the last year, FRES has been closely correlated with HOOK. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if FRES jumps, then HOOK could also see price increases.
Ticker / NAME | Correlation To FRES | 1D Price Change % | ||
---|---|---|---|---|
FRES | 100% | +4.67% | ||
HOOK - FRES | 75% Closely correlated | -15.44% | ||
KZIA - FRES | 57% Loosely correlated | -1.43% | ||
NKTR - FRES | 34% Loosely correlated | +1.00% | ||
QURE - FRES | 32% Poorly correlated | +2.54% | ||
KPRX - FRES | 31% Poorly correlated | -3.22% | ||
More |